Issn Print: 0036-8075
Publication Date: 2014/05/30
DRUG DEVELOPMENTTarget small firms for antibiotic innovation
Thomas J. Hwang; Daniel Carpenter; Aaron S. Kesselheim
Author Information: Faculty of Arts and Sciences, Harvard University, Cambridge, MA 02138, USA.
|Checking for direct PDF access through Ovid|
Once in clinical trials, antibiotics are more likely to survive than drugs in other classes